Proinnovera Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
1
Proinnovera General Information
Description
Operator of a contract research organization intended for the dermatology clinical trial space. The company offers various services such as medical writing, quality assurance, clinical monitoring, data management and biostatic services, and managing clinical trials (phase I to IV) for drugs and medical devices, thereby turning study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials.
Contact Information
Website
www.proinnovera.com(Operating Subsidiary)
Corporate Office
- Wienburgstrasse 207
- 48159 Muenster
- Germany
Corporate Office
- Wienburgstrasse 207
- 48159 Muenster
- Germany
Proinnovera Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Proinnovera Comparisons
Industry
Financing
Details
Proinnovera Competitors (11)
One of Proinnovera’s 11 competitors is Parexel International, a Private Equity-Backed company based in Raleigh, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Parexel International | Private Equity-Backed | Raleigh, NC | ||||
| The Emmes Company | Private Equity-Backed | Rockville, MD | ||||
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| CTI Clinical Trial and Consulting | Private Equity-Backed | Covington, KY | ||||
| Cromos Pharma | Corporation | Dublin, Ireland |
Proinnovera Signals
Proinnovera Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Proinnovera Investments (1)
Proinnovera’s most recent deal was a Buyout/LBO with Symbio Research. The deal was made on 10-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Symbio Research | 10-Nov-2023 | Buyout/LBO | Systems and Information Management |
Proinnovera FAQs
-
When was Proinnovera founded?
Proinnovera was founded in 2007.
-
Where is Proinnovera headquartered?
Proinnovera is headquartered in Muenster, Germany.
-
What is the size of Proinnovera?
Proinnovera has 50 total employees.
-
What industry is Proinnovera in?
Proinnovera’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Proinnovera a private or public company?
Proinnovera is a Private company.
-
What is Proinnovera’s current revenue?
The current revenue for Proinnovera is .
-
Who are Proinnovera’s investors?
TKL Research has invested in Proinnovera.
-
Who are Proinnovera’s competitors?
Parexel International, The Emmes Company, North American Science Associates, CTI Clinical Trial and Consulting, and Cromos Pharma are some of the 11 competitors of Proinnovera.
-
When was Proinnovera acquired?
Proinnovera was acquired on 17-Nov-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process